India and Brazil signed an agreement to cooperate on pharmaceutical regulations, aiming to improve safety, quality, and access to medical products.

A promising nasal spray vaccine in mice offers broad, long-lasting protection against flu, COVID-19, colds, pneumonia, and allergens with just one dose, potentially eliminating annual shots, but human trials are still needed.

Gilead acquires Arcellx for $7.8B to gain control of anito-cel, a potential multiple myeloma therapy, with deal closing in Q2 2026.

Women experience longer pain after injury due to biological differences in immune cells, a study finds.

FDA proposes fast-tracking gene therapies for rare diseases with strong scientific basis.

A UK baby, Hugo Powell, is the first born from a womb transplant using a deceased donor, offering new hope for women with uterine infertility.

Cats and humans share key cancer genes, with study revealing similar tumor mutations and treatment responses, advancing precision medicine for both.

Eli Lilly's orforglipron outperformed semaglutide in lowering blood sugar and weight in type 2 diabetes patients, with FDA decision expected in Q2 2026.

Novo Nordisk partners with Vivtex on $2.1B deal to develop oral diabetes and obesity drugs using advanced delivery tech.

Eris and Natco to launch generic semaglutide in India in March 2026 post-patent expiry.